Aurora Spine logo

Aurora Spine(OTC) ASAPF

Market Cap$7.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-94%
5 Year-69%
1 Year-53%
1 Month-23%
$0.10
+21.07%
+0.02Today
Aurora Spine last closing stock price
MetricPriceDate
Last closeUSD 0.102026-10-08
Aurora Spine stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.42%USD 0.102026-09-30
1 month-23.08%USD 0.132026-09-08
3 month-42.26%USD 0.172026-07-10
Year to date-50%USD 0.202025-12-31
1 year-53.05%USD 0.212025-10-08
3 year-62.7%USD 0.272023-10-06
5 year-68.69%USD 0.322021-10-08
Since inception-93.83%USD 1.342013-09-26

Aurora Spine Financials at a Glance

Market Cap

$7.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$17.42M

Net Income (TTM)

-$1.20M

EPS (TTM)

-$0.02

P/E Ratio

-6.41

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$0.10

Volume

25,500

Open

$0.10

Previous Close

$0.10

Daily Range

$0.10 - $0.10

52-Week Range

$0.07 - $0.24

Estimated Earnings Date

Nov 16, 2026

ASAPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aurora Spine

Aurora Spine Corporation specializes in the development and distribution of advanced, minimally invasive spine fusion systems and related medical devices. The company offers a diverse product portfolio designed to treat patients suffering from degenerative disc diseases.

Products and Services
  • Interspinous process lumbar fusion devices, including the ZIP and ZIP ULTRA lines
  • Titanium-coated PEEK interbody cages for spinal stability
  • 3D-printed spinal implants like the SOLO and DEXA-C systems
Growth Outlook
  • Increasing demand for minimally invasive spine surgeries supports product growth
  • Expansion into new markets enhances revenue potential
  • Innovative product development drives competitive advantage
Financial Highlights
  • Q2 2026 revenue of $3.57 million, showing a strong market presence
  • Trailing twelve months gross profit margin at 41.8%, indicating operational efficiency
  • Current ratio of 2.25, reflecting solid liquidity position
Aurora Spine Corporation has established itself as a key player in the medical devices industry, particularly in the spine surgery segment. The company's innovative approach to product development, including 3D-printed devices, positions it well for future growth. Recent financial performance indicates a solid revenue stream and operational efficiency, which may attract potential investors looking for opportunities in the healthcare sector. The company's focus on minimally invasive solutions aligns with current trends in patient care, further enhancing its market appeal.
AI Generated • Sep 15, 2026

Industry

Healthcare Equipment and Supplies

CEO

Trent J. Northcutt

Headquarters

Toronto, ON M4S 3B1, CA

ASAPF Financials

Key Financial Metrics (TTM)

Gross Margin

41.85%

Operating Margin

-4.98%

Net Income Margin

-6.95%

Return on Equity

-34.32%

Return on Capital

-5.51%

Return on Assets

-13.55%

Earnings Yield

-15.60%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

78.09M

Volume

25.50K

Avg. Volume

12.40K

Financials (TTM)

Gross Profit

$3.94M

Operating Income

-$866.02K

EBITDA

$221.30K

Operating Cash Flow

$708.81K

Capital Expenditure

-$458.43K

Free Cash Flow

$250.38K

Cash & ST Invst.

$362.20K

Total Debt

$2.17M

Aurora Spine Performance Analysis

Aurora Spine annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 14,877,32441.1%
20232023-12-31USD 14,520,436-2.4%
20242024-12-31USD 17,562,78221.0%
20252025-12-31USD 18,368,0284.6%
Aurora Spine sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-2.6%
Q42025-12-3116.4%
Q12026-03-31-14.2%
Q22026-06-30-18.5%
Aurora Spine annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.02-44.0%
20232023-12-31USD -0.025.8%
20242024-12-31USD -0.01-45.8%
20252025-12-31USD -0.01-27.1%
Aurora Spine sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3030.8%
Q42025-12-3166.7%
Q12026-03-31-333.3%
Q22026-06-30-300.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.57M

-20.7%

Gross Profit

$468.48K

-83.3%

Gross Margin

13.14%

N/A

Market Cap

$7.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$433.84K

N/A

Employees

18

N/A

Net Income

-$813.57K

-309.3%

EBITDA

-$525.69K

-527.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$362.20K

-37.7%

Total Debt

$2.17M

-40.3%

Accounts Receivable

$2.65M

-35.2%

Inventory

$3.38M

-11.7%

Long Term Debt

$1.85M

-44.5%

Short Term Debt

$318.42K

+4.7%

Return on Assets

-13.55%

N/A

Return on Invested Capital

-14.48%

N/A

Free Cash Flow

-$309.45K

-311.3%

Operating Cash Flow

-$171.25K

-185.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UEECUnited Health Products, Inc.
$0.04+7.50%
VPTDFVentriPoint Diagnostics Ltd.
$0.06-1.09%
IMMVFImmunovia AB
$0.01+0.00%
BTCYBiotricity, Inc.
$0.05-0.55%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$107.08-5.34%
NVDANvidia
$230.48-2.94%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.79+10.24%
BITOProShares Trust - ProShares Bitcoin ETF
$10.93-1.88%

Questions About ASAPF

What is the current price of Aurora Spine?

Aurora Spine is trading at $0.10 per share.

What is the 52-week range for Aurora Spine?

Over the past 52 weeks, Aurora Spine has traded between $0.07 and $0.24.

How much debt does Aurora Spine have?

As of the most recent reporting period, Aurora Spine reported total debt of $2.17M.

How much cash does Aurora Spine have on hand?

Aurora Spine reported $362.63K in cash and cash equivalents in its most recent financial results.

What is Aurora Spine’s dividend yield?

Aurora Spine does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.